Evidence map›Paper›PMID 41359379›Full record

ReviewNucleic acids research2025

The lysosomal catabolism of nucleic acids-critical regulators of the innate immune system.

Cedric Cappel, Markus Damme

Abstract readReview
In one paragraph

Review in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cedric CappelInstitut für Biochemie, Christian-Albrechts-Universität zu Kiel, Kiel 24098, Germany.ORCID 0000-0002-3333-3528
Markus DammeInstitut für Biochemie, Christian-Albrechts-Universität zu Kiel, Kiel 24098, Germany.ORCID 0000-0002-9699-9351

Funding

Deutsche Forschungsgemeinschaft DA 1785/1-1Deutsche Forschungsgemeinschaft DA 1785/2-1
6 · The paper itself

Abstract

Lysosomes play a pivotal role in degrading and recycling cellular macromolecules, including nucleic acids. Notably, nucleic acids are critical modulators of the innate immunity sensed in endo-/lysosomes, highlighting the relevance of their rapid and tightly regulated turnover. This review explores the intricate processes governing the uptake routes of nucleic acids into lysosomes, the lysosomal catabolism of DNA and RNA to nucleosides and phosphate, and the export of the degradation products, emphasizing the key enzymes and proteins, regulatory mechanisms, and pathological implications of impaired degradation. We highlight open questions in this process and discuss controversies in the field. We discuss the interdependence of efficient nucleic acid degradation and endo-/lysosomal nucleic acid sensors (Toll-like receptors) and pathological implications in human diseases as a result of impaired nucleic acid degradation, e.g. in genetic deficiency disorders resulting in loss-of-function of critical enzymes. This review integrates current research findings, highlighting the significance of lysosomal nucleic acid catabolism in cellular physiology and its link to disease pathogenesis, and hopefully stimulates research in the field that will finally fully comprehend this complex interplay between lysosomal degradation and immunity.

Indexed as

Immunity, InnateLysosomesNucleic AcidsAnimalsDNAHumansRNAToll-Like ReceptorsDNANucleic AcidsRNAToll-Like Receptors

Identifiers

PMID41359379
PMCPMC12684396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.